Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Adrenal tumors: current standards in clinical management].
Fuß CT, Megerle F, Fassnacht M. Fuß CT, et al. Among authors: megerle f. Inn Med (Heidelb). 2024 Jun 12. doi: 10.1007/s00108-024-01727-x. Online ahead of print. Inn Med (Heidelb). 2024. PMID: 38864873 Review. German.
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.
Terzolo M, Fassnacht M, Perotti P, Libé R, Kastelan D, Lacroix A, Arlt W, Haak HR, Loli P, Decoudier B, Lasolle H, Quinkler M, Haissaguerre M, Chabre O, Caron P, Stigliano A, Giordano R, Zatelli MC, Bancos I, Fragoso MCBV, Canu L, Luconi M, Puglisi S, Basile V, Reimondo G, Kroiss M, Megerle F, Hahner S, Kimpel O, Dusek T, Nölting S, Bourdeau I, Chortis V, Ettaieb MH, Cosentini D, Grisanti S, Baudin E, Berchialla P, Bovis F, Sormani MP, Bruzzi P, Beuschlein F, Bertherat J, Berruti A. Terzolo M, et al. Among authors: megerle f. Lancet Diabetes Endocrinol. 2023 Oct;11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6. Epub 2023 Aug 21. Lancet Diabetes Endocrinol. 2023. PMID: 37619579 Free PMC article. Clinical Trial.
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma.
Kimpel O, Schindler P, Schmidt-Pennington L, Altieri B, Megerle F, Haak H, Pittaway J, Dischinger U, Quinkler M, Mai K, Kroiss M, Polat B, Fassnacht M. Kimpel O, et al. Among authors: megerle f. Br J Cancer. 2023 Feb;128(4):586-593. doi: 10.1038/s41416-022-02082-0. Epub 2022 Dec 8. Br J Cancer. 2023. PMID: 36482186 Free PMC article.
Management of Patients With Glucocorticoid-Related Diseases and COVID-19.
Chifu I, Detomas M, Dischinger U, Kimpel O, Megerle F, Hahner S, Fassnacht M, Altieri B. Chifu I, et al. Among authors: megerle f. Front Endocrinol (Lausanne). 2021 Sep 14;12:705214. doi: 10.3389/fendo.2021.705214. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34594302 Free PMC article. Review.
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question.
Basile V, Puglisi S, Altieri B, Canu L, Libè R, Ceccato F, Beuschlein F, Quinkler M, Calabrese A, Perotti P, Berchialla P, Dischinger U, Megerle F, Baudin E, Bourdeau I, Lacroix A, Loli P, Berruti A, Kastelan D, Haak HR, Fassnacht M, Terzolo M. Basile V, et al. Among authors: megerle f. J Pers Med. 2021 Apr 4;11(4):269. doi: 10.3390/jpm11040269. J Pers Med. 2021. PMID: 33916613 Free PMC article.
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.
Weigand I, Altieri B, Lacombe AMF, Basile V, Kircher S, Landwehr LS, Schreiner J, Zerbini MCN, Ronchi CL, Megerle F, Berruti A, Canu L, Volante M, Paiva I, Della Casa S, Sbiera S, Fassnacht M, Fragoso MCBV, Terzolo M, Kroiss M. Weigand I, et al. Among authors: megerle f. J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa293. doi: 10.1210/clinem/dgaa293. J Clin Endocrinol Metab. 2020. PMID: 32449514 Free article.
19 results